Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax

The unpredictable nature of bioterrorism and the absence of real-time detection systems have highlighted the need for an efficient postexposure therapy for Bacillus anthracis infection. One approach is passive immunization through the administration of antibodies that mitigate the biological action...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Albrecht, Mark T., Li, Han, Williamson, E. Diane, LeButt, Chris S., Flick-Smith, Helen C., Quinn, Conrad P., Westra, Hans, Galloway, Darrell, Mateczun, Alfred, Goldman, Stanley, Groen, Herman, Baillie, Les W. J.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2007
Teme:
Microbial Immunity and Vaccines
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2168292/
https://ncbi.nlm.nih.gov/pubmed/17646360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00261-07
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items